These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 28975126)
1. Pattern of occurrence and treatment outcome of second primary malignancies: A single center experience. Chaudhary P; Gupta S; Leekha N; Tandon R; Nandy M; De S South Asian J Cancer; 2017; 6(3):137-138. PubMed ID: 28975126 [TBL] [Abstract][Full Text] [Related]
2. Second primary malignancy: A retrospective analysis report from a tertiary cancer center of North India. Sharma D; Singh G; Kakkar N; Raj S Indian J Cancer; 2016; 53(4):595-599. PubMed ID: 28485361 [TBL] [Abstract][Full Text] [Related]
3. Second primary malignant neoplasms: a clinicopathological analysis from a cancer centre in India. Hulikal N; Ray S; Thomas J; Fernandes DJ Asian Pac J Cancer Prev; 2012; 13(12):6087-91. PubMed ID: 23464409 [TBL] [Abstract][Full Text] [Related]
4. Dual malignancies in the setting of differentiated thyroid carcinoma: their synchronous or metachronous nature, impact of radioiodine treatment on occurrence of second malignancy and other associated variables. Gandhi S; Abhyankar A; Basu S Nucl Med Commun; 2014 Feb; 35(2):205-9. PubMed ID: 24217429 [TBL] [Abstract][Full Text] [Related]
6. Impact of second primary malignancy on outcomes of differentiated thyroid carcinoma. Lang BH; Lo CY; Wong IO; Cowling BJ Surgery; 2010 Dec; 148(6):1191-6; discussion 1196-7. PubMed ID: 21134551 [TBL] [Abstract][Full Text] [Related]
7. Second cancer incidence, risk factor, and specific mortality in head and neck squamous cell carcinoma. Lee DH; Roh JL; Baek S; Jung JH; Choi SH; Nam SY; Kim SY Otolaryngol Head Neck Surg; 2013 Oct; 149(4):579-86. PubMed ID: 23820107 [TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics of second primary malignancies among first primary malignancy survivors: A single-center study, 2005-2020. Geng F; Liu M; Chen J; Ge Y; Wei S; Li F; Yang C; Sun J; Gou L; Zhang J; Tang S; Wan Y; Yang J; Zhang J Oncol Lett; 2023 Jan; 25(1):24. PubMed ID: 36478913 [TBL] [Abstract][Full Text] [Related]
9. Double primary malignancies: a clinical & pathological analysis report from a regional cancer institute in India. Bagri PK; Singh D; Singhal MK; Singh G; Mathur G; Jakhar SL; Beniwal S; Sharma N; Kumar HS; Sharma A; Bardia MR Iran J Cancer Prev; 2014; 7(2):66-72. PubMed ID: 25250152 [TBL] [Abstract][Full Text] [Related]
10. Risk Assessment of Secondary Primary Malignancies in Nasopharyngeal Carcinoma: A Big-Data Intelligence Platform-Based Analysis of 6,377 Long-term Survivors from an Endemic Area Treated with Intensity-Modulated Radiation Therapy during 2003-2013. Zhang LL; Li GH; Li YY; Qi ZY; Lin AH; Sun Y Cancer Res Treat; 2019 Jul; 51(3):982-991. PubMed ID: 30309219 [TBL] [Abstract][Full Text] [Related]
11. Multiple Primary Malignancies in Head and Neck Cancer: A University Hospital Experience Over a Five-Year Period. Batista MV; Ulrich J; Costa L; Ribeiro LA Cureus; 2021 Aug; 13(8):e17349. PubMed ID: 34567890 [TBL] [Abstract][Full Text] [Related]
12. Incidence of Nonthyroidal Primary Malignancy and the Association with (131)I Treatment in Patients with Differentiated Thyroid Cancer. Hirsch D; Shohat T; Gorshtein A; Robenshtok E; Shimon I; Benbassat C Thyroid; 2016 Aug; 26(8):1110-6. PubMed ID: 27302111 [TBL] [Abstract][Full Text] [Related]
13. Metachronous Second Primary Malignancies after Head and Neck Cancer in a Korean Cohort (1993-2010). Jung YS; Lim J; Jung KW; Ryu J; Won YJ PLoS One; 2015; 10(7):e0134160. PubMed ID: 26218068 [TBL] [Abstract][Full Text] [Related]
14. Neuroendocrine tumors and second primary malignancy--a relationship with clinical impact? Prommegger R; Ensinger C; Steiner P; Sauper T; Profanter C; Margreiter R Anticancer Res; 2004; 24(2C):1049-51. PubMed ID: 15154621 [TBL] [Abstract][Full Text] [Related]
15. Synchronous and metachronous head and neck carcinomas. Schwartz LH; Ozsahin M; Zhang GN; Touboul E; De Vataire F; Andolenko P; Lacau-Saint-Guily J; Laugier A; Schlienger M Cancer; 1994 Oct; 74(7):1933-8. PubMed ID: 8082099 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic Outcome of Second Primary Malignancies in Patients with Well-Differentiated Thyroid Cancer. Liou MJ; Tsang NM; Hsueh C; Chao TC; Lin JD Int J Endocrinol; 2016; 2016():9570171. PubMed ID: 27118971 [TBL] [Abstract][Full Text] [Related]
17. Clinical and Prognostic Analysis of Hypopharyngeal Squamous Cell Carcinoma with Synchronous and Metachronous Multiple Malignancies. Yamamoto K; Takano K; Kondo A; Kurose M; Obata K; Himi T In Vivo; 2018; 32(1):165-170. PubMed ID: 29275315 [TBL] [Abstract][Full Text] [Related]
18. Incidence of second primary malignancies in patients with esophageal cancer: a comprehensive review. Nandy N; Dasanu CA Curr Med Res Opin; 2013 Sep; 29(9):1055-65. PubMed ID: 23777310 [TBL] [Abstract][Full Text] [Related]
19. The impact of age at the time of radiotherapy for localized prostate cancer on the development of second primary malignancies. Krasnow RE; RodrÃguez D; Nagle RT; Mossanen M; Kibel AS; Chang SL Urol Oncol; 2018 Nov; 36(11):500.e11-500.e19. PubMed ID: 30249519 [TBL] [Abstract][Full Text] [Related]
20. Synchronous and metachronous malignancies: analysis of the Minneapolis Veterans Affairs (VA) tumor registry. Powell S; Tarchand G; Rector T; Klein M Cancer Causes Control; 2013 Aug; 24(8):1565-73. PubMed ID: 23737025 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]